Evidence-based dry-eye therapies for clinical use
8 October 2021
Volume 22, Issue 3
This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.
Domains covered
Professionalism
Clinical practice
Specialty CPD (IP)
Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Adrian O’Dowd explores whether the global rises in myopia and diabetes are linked and whether insulin resistance and diet can affect sight.
Some tree and grass pollens emerge in February. Other allergens come all year round. Anna Scott asks what optometrists need to know to support allergy sufferers.
In this live webinar, Ms Nishani Amerasinghe, a Consultant Ophthalmic Surgeon, will give an overview of PAC, PACG and PACS.